Drawing for HUMAX-CD20

USPTO serial 79026567

HUMAX-CD20

Reviewed by CopyMark Law Group

Reg. 3237702Status 404
Filing date
Status date
Registration date
May 1, 2007
Examiner
OTT, CHRISTOPHER
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HUMAX-CD20?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry, science namely monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseasesSECTION 71 - CANCELLED—
005Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseasesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 2, 2016DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Oct 2, 2016DETHDEATH OF INTERNATIONAL REGISTRATION—
Jun 20, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Feb 5, 2015INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 5, 2015INPCINVALIDATION PROCESSED—
Aug 6, 2014INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 6, 2013C71TCANCELLED SECTION 71—
Nov 11, 2011NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 15, 2010ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 9, 2007FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 19, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 17, 2007FIMPFINAL DISPOSITION PROCESSED—
Oct 3, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 1, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 13, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 24, 2007NPUBNOTICE OF PUBLICATION—
Dec 18, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 18, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 15, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 15, 2006ALIEASSIGNED TO LIE—
Nov 16, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 16, 2006MAILPAPER RECEIVED—
Oct 6, 2006RFNTREFUSAL PROCESSED BY IB—
Sep 15, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 15, 2006RFRRREFUSAL PROCESSED BY MPU—
Sep 13, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 12, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2006DOCKASSIGNED TO EXAMINER—
Sep 8, 2006NWAPNEW APPLICATION ENTERED—
Sep 7, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance